JP Patent
JP6193970B2 — 黄色ブドウ球菌(Staphylococcusaureus)に対するデルフィニジンの使用
Assigned to Sapiotec GmbH · Expires 2017-09-06 · 9y expired
What this patent protects
Patent listed against Zulresso.
Drugs covered by this patent
- Zulresso (BREXANOLONE) · Sage Therap
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.